Gene · 10020
Papers4,261
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,261
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycosyltransferases: glycoengineers in human milk oligosaccharide synthesis and manufacturing. | Front Mol Biosci | 2025 | 40370521 | PubTator, text mining | PubMed |
| The detection, function, and therapeutic potential of RNA 2'-O-methylation. | Innov Life | 2025 | 40206865 | PubTator, text mining | PubMed |
| Analysis of the pathogenicity of novel GNE mutations and clinical, pathological, and genetic characteristics of GNE myopathy in Chinese population. | Orphanet J Rare Dis | 2025 | 40188109 | PubTator, text mining | PubMed |
| Efficacy of sialic acid supplementation in early life in autism model rats. | Sci Rep | 2025 | 40075137 | PubTator, text mining | PubMed |
| Beyond sialylation: Exploring the multifaceted role of GNE in GNE myopathy. | Mol Genet Metab | 2025 | 40054019 | PubTator, text mining | PubMed |
| The study of pubertal stage and age of menarche in girls in Isfahan province, Iran. | BMC Pediatr | 2025 | 39891122 | PubTator, text mining | PubMed |
| CompSafeNano project: NanoInformatics approaches for safe-by-design nanomaterials. | Comput Struct Biotechnol J | 2025 | 39872495 | PubTator, text mining | PubMed |
| Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro. | Blood Adv | 2025 | 39820328 | PubTator, text mining | PubMed |
| Clinical features, mutation spectrum and factors related to reaching molecular diagnosis in a cohort of patients with distal myopathies. | J Neurol | 2025 | 39775307 | PubTator, text mining | PubMed |
| Advanced reactivity-based sequencing methods for mRNA epitranscriptome profiling. | RSC Chem Biol | 2025 | 39759443 | PubTator, text mining | PubMed |
| [Aceneuraminic acid for distal myopathy]. | Nihon Yakurigaku Zasshi | 2025 | 39756906 | PubTator, text mining | PubMed |
| Calcium level and autophagy defect in GNE mutants of rare neuromuscular disorder. | Cell Biol Int | 2025 | 39707730 | PubTator, text mining | PubMed |
| A pilot trial for efficacy confirmation of 6'-sialyllactose supplementation in GNE myopathy: Randomized, placebo-controlled trial. | Mol Genet Metab | 2025 | 39644669 | PubTator, text mining | PubMed |
Preserved Forearm and Hand Muscles and Diaphragm with Mild Cardiac and Respiratory Involvement in a Patient with GNE Myopathy Harboring Homozygous Variants in GNE (c.1807G>C, p.V603L) over Four Decades after the Onset. | Intern Med | 2025 | 39428522 | PubTator, text mining | PubMed |
| Computational insights into dynamics and conformational stability of N-acetylmannosamine kinase mutations. | J Biomol Struct Dyn | 2025 | 38502682 | PubTator, text mining | PubMed |
| Estimating the Prevalence of GNE Myopathy Using Population Genetic Databases. | Hum Mutat | 2024 | 40225917 | PubTator, text mining | PubMed |
| The frequent variant A57F in the GNE gene in patients from Russia has Finno-Ugric Mari origin. | Front Genet | 2024 | 39722797 | PubTator, text mining | PubMed |
| The Role of ETNPPL in Dopaminergic Neuron Stability: Insights from Neuromelanin-Associated Protein Expression in Parkinson's Disease. | Int J Mol Sci | 2024 | 39684817 | PubTator, text mining | PubMed |
| Novel biallelic GNE variants identified in a patient with chronic thrombocytopenia without any symptoms of myopathy. | Ann Hematol | 2024 | 39576359 | PubTator, text mining | PubMed |
| Nmix: a hybrid deep learning model for precise prediction of 2'-O-methylation sites based on multi-feature fusion and ensemble learning. | Brief Bioinform | 2024 | 39550226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10020/papers?page=5